1.Review published literature regarding RKF and decreased mortality in the hemodialysis population.
2.Evaluate whether RKF can be “clinically negligible” or if any degree of RKF is “metabolically significant.”
3.Reframe how nephrologists view RKF and its relationship with certain non-urea solutes.
Wednesday, August 9, 2017 - 4:00pm to 5:00pm
Stephanie Toth-Manikowski, MD
Chicago, IL 60637
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation